Tag: David Holtzman

Tau-based biomarker tracks Alzheimer’s progression

Two pathologies drive the progression of Alzheimer’s disease. Early on, amyloid beta plaques lead the way, but around the time cognitive symptoms arise, tau tangles take over as the driving force and cognition steadily declines. Tracking the course of the disease in individual patients has been challenging because there’s been no easy way to measure […]

Neuroscience leaders tour research building construction site

Neuroscience leaders and other faculty and staff at Washington University School of Medicine in St. Louis got an up-close look at the Neuroscience Research Building during a recent tour of the construction site. The framework of all 11 stories has been built, and the process of wrapping the building in glass is underway. On the […]